eToro surges in IPO debut, pushing valuation to $6 billion
Investing.com -- Global online broker eToro Group Ltd (NASDAQ:ETOR) surged in its IPO debut Wednesday. Shares opened at $69.69 after pricing at $52. The stock last traded at $72.25, up about 39%.
Overnight, the company priced its upsized IPO of 11,923,018 common shares, up from 10 million, at $52, which was above the expected $46-$50 range.
The company and selling shareholders raised $620 million in the deal.
The company sold 5,961,509 shares in the offering, and selling shareholders, including CEO and founder Yoni Assia, are selling the other 5,961,509 shares.
The offering is being led by Goldman Sachs, Jefferies, UBS and Citigroup (NYSE:C). The underwriters have been granted an option to purchase up to an additional 1.79 million shares.
Cornerstone investor Blackrock (NYSE:BLK), Inc. has indicated an interest in purchasing up to an aggregate of $100 million class A common shares in the IPO.
As many as 82.37 million Class A and Class B shares will be outstanding immediately following the offering, suggesting a total valuation of nearly $6 billion based on the current price level.
Founded in 2007, eToro boasted over 3.5 million funded accounts in 75 countries as of the end of 2024.
eToro has been a pioneer in the crypto space. The company was among the first EU-regulated brokers to offer Bitcoin. Further, CEO Assia, co-authored the Colored Coins white paper with Ethereum creator Vitalik Buterin—one of the earliest protocols for asset tokenization on Bitcoin.
Net contribution was $787 million in 2024, up 41% from the prior year. Total commission for the year was up 46% to $931 million. Net income for 2024 surged 1,161% to $192 million.
Related articles
eToro surges in IPO debut, pushing valuation to $6 billion
MNTN Files for IPO, targeting up to $187 million
Apple Vision Pro to allow eye-scrolling, Bloomberg reports
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
FREMONT, Calif., June 03, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new results from the CALLA phase 3 study showing for the first time its ultrasensitive NeXT Personal circulating tumor DNA (ctDNA) blood test detected cervical cancer progression, up to 16 months ahead of imaging. The results demonstrate the potential of NeXT Personal to enable earlier detection in a cancer with high recurrence rates. The results were presented yesterday by Jyoti Mayadev, MD, from the University of California San Diego, at the American Society for Clinical Oncology (ASCO) 2025 Annual Meeting in Chicago in an oral presentation titled "Ultrasensitive detection and tracking of circulating tumor DNA (ctDNA) and association with relapse and survival in locally advanced cervical cancer (LACC): Phase 3 CALLA trial analyses." The results from this study were also simultaneously published in the journal Annals of Oncology. Samples were analyzed from patients with cervical cancer who had enrolled in the original CALLA clinical trial. In this new study analysis, NeXT Personal was used to look for small traces of ctDNA in blood samples from a cohort of 186 patients with locally advanced cervical cancer. Dr. Mayadev's team found that overall ctDNA levels after chemoradiotherapy (CRT) treatment were strongly predictive of risk of cervical cancer progression. "Despite standard chemoradiotherapy, up to half of patients with locally advanced cervical cancer relapse, underscoring the urgent need for better prognostic tools. In the CALLA phase 3 study, ultrasensitive, tumor-informed ctDNA analysis emerged as a powerful predictor of progression and survival—detecting relapse up to ~16 months before imaging. These findings highlight ctDNA's potential to guide treatment decisions and personalize care in high-risk cervical cancer," said Dr. Mayadev. Key findings presented: Detection of ctDNA following CRT was independently prognostic of patient outcomes. Risk of progression and death were at least 95% lower for patients where ctDNA was not detected ~3 months after completing CRT. Detection of ctDNA after CRT was associated with high subsequent risk of disease progression, and was detected a median of ~5 months and up to ~16 months earlier than by imaging scans. High ctDNA levels (≥ median) at baseline was associated with higher risk of progression and death. "We are excited to see the results presented for NeXT Personal in this large phase 3 study in cervical cancer," said Richard Chen, MD, Chief Medical Officer and Executive Vice President, R&D at Personalis. "Cervical cancer is the fourth most common cancer for women globally, resulting in hundreds of thousands of deaths each year. The new results show the strong potential for an ultrasensitive MRD test like NeXT Personal to inform treatment for cervical cancer patients." About Personalis, Inc. At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care throughout the patient journey. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit and connect with us on LinkedIn and X (Twitter). Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this press release that are not historical are "forward-looking statements" within the meaning of U.S. securities laws, including statements relating to the attributes, advantages, sensitivity, clinical relevance or importance of the NeXT Personal test. Such forward-looking statements involve known and unknown risks and uncertainties and other factors that may cause actual results to differ materially from any anticipated results or expectations expressed or implied by such statements, including the risks, uncertainties and other factors that relate to the ability of NeXT Personal to detect small traces of ctDNA, detect residual or recurrent cancer early (including detection earlier than standard of care imaging), monitor or predict a patient's response to therapy or risk of cancer recurrence, accurately predict clinical outcomes for cancer patients, or impact cancer care or management (including for escalation or de-escalation of treatment), or to the clinical adoption or use of, or the ability of Personalis to obtain Medicare coverage or reimbursement for, the NeXT Personal test, or to the sufficiency of the publication and study results described in this press release to support such adoption, use, coverage or reimbursement. These and other potential risks and uncertainties that could cause actual results to differ materially from the results predicted in these forward-looking statements are described under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Personalis' Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (SEC) on February 27, 2025, and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on May 6, 2025. All information provided in this release is as of the date of this press release, and any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of this date. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. Personalis undertakes no duty to update this information unless required by law. Not affiliated with or endorsed by ASCO. View source version on Contacts Investors: Caroline Cornerinvestors@ 415-202-5678 Media Contact pr@
Yahoo
26 minutes ago
- Yahoo
Can you still make money with Bitcoin?
(NewsNation) — Bitcoin is often hailed as digital gold, and on social media, it can feel like a modern-day gold rush. On TikTok, crypto-influencers hype up lavish lifestyles, interviewing self-proclaimed Bitcoin billionaires surrounded by luxury cars. Bitcoin, a form of digital currency that can be traded online without relying on traditional banks, has skyrocketed in value since its humble beginnings in 2009. One Bitcoin is currently worth around $110,000 — roughly quadruple its value just two years ago. So is it too late to get in on the action? Here's what to know. 'Why It's Not Too Late To Buy Bitcoin' (YouTube) 'Bitcoin: The Ultimate Wealth Storage!!' (TikTok) 'Meet the Youngest Bitcoin Billionaire $100,000,000 car collection' (TikTok) When it comes to cryptocurrency, Bitcoin is the biggest name in town and it's not even close. With a market cap of over $2 trillion as of this writing, Bitcoin is more valuable than Costco, Walmart and Netflix combined. Like stocks, the value of Bitcoin fluctuates from one day to the next. Are ChatGPT-written children's books an easy side hustle? Buying and selling Bitcoin is fairly straightforward. You can purchase a Bitcoin (or fractions of a Bitcoin) with U.S. dollars through an online cryptocurrency exchange like Coinbase or a more traditional investment broker like Robinhood. That transaction is recorded on the blockchain — a decentralized, secure digital ledger that isn't controlled by banks or governments. 'There is truly revolutionary technology underlying these cryptocurrencies, including Bitcoin, that allow money and value to flow outside of a government-sponsored fiat currency,' said Jennifer Schulp, director of financial regulation studies at the Libertarian-leaning Cato Institute. That said, Schulp worries influencer buzz could do more harm than good for digital assets in the long run. 'Viewing it all as, 'how do you make a buck in the quickest way possible' is not beneficial to the long-term innovation that can be seen from this space,' she said. The price of Bitcoin could go up or down. Nobody knows. That's true of other investments like stocks or gold, but Bitcoin has a few additional risks. Historically, it's been more volatile than traditional asset classes. Bitcoin has gone up over the long run, but price swings have been the norm, not the exception. If you bought Bitcoin at its November 2021 high, your investment would have been worth roughly half as much about three months later. On the other hand, buying in early Feb. 2024 would have resulted in a significant gain after only a month — about 60%. At times, those fluctuations have been more a reflection of crypto-enthusiasm than so-called 'market fundamentals,' the tangible economic indicators investors use to gauge the stock market. In that sense, Bitcoin requires investors to pay attention. Making fast money on vending machines: Is it that easy? 'I don't think it's just a set it and forget it investment because of its volatility, because of all the different macro factors influencing it,' said Bryan Armour, director of passive strategies research at Morningstar. It's worth noting that Bitcoin has been less volatile than many individual stocks, even popular names like Meta, Nvidia and Tesla, according to a Fidelity Digital Assets analysis in 2024. Bitcoin has only been around for 16 years, while the New York Stock Exchange dates back hundreds of years. With time comes information. Investors can look at previous economic cycles and know with some confidence where stocks are headed in the future. Since its introduction in 1957, for example, the S&P 500 has delivered an annual average return of around 10%. Bitcoin has done even better over the past decade, averaging an almost 50% annual return, but there's no guarantee that success will continue. 'Predicting where [Bitcoin] is going to go when there's an economic shock, I think we just don't know yet,' Schulp said. And unlike stocks, which represent ownership in real companies, Bitcoin isn't backed by physical assets. Its value comes from scarcity, hence the comparison to 'digital gold.' But even that analogy is imperfect. Gold is something you can hold and the world's most powerful governments keep it in strategic reserves. That could happen with Bitcoin, but it hasn't unfolded in the same way yet. The U.S. doesn't have a clear regulatory framework for digital assets, though several cryptocurrency bills and regulations are in the works. 'Part of the risk of it is that it's unknown how these things are going to be regulated five years from now versus one year from now,' Armour said. Is meme coin crypto the key to get rich quick or another scam? Bitcoin investors are optimistic that the Trump administration will be positive for the crypto industry, with Trump poised to be the most pro-crypto president ever. Even so, the ongoing uncertainty makes crypto a risky investment. Ray Dalio, a prolific investor, called Bitcoin 'one hell of an invention' back in 2021, but cautioned: 'I suspect that Bitcoin's biggest risk is being successful, because if it's successful, the government will try to kill it and they have a lot of power to succeed.' In 2023, Dalio said he has 'a little bit' of crypto in his portfolio but acknowledged the risks: 'I've seen people get very rich and I've seen people get very broke with it.' Other big-name investors, like Warren Buffett and Jamie Dimon, have been vocal critics of crypto over the years. Most Americans remain skeptical for now. Roughly six-in-ten (63%) say they have little to no confidence that current ways to invest in, trade, or use cryptocurrencies are reliable and safe, according to Pew Research. Overall, just 17% of U.S. adults have ever invested in, traded or used a cryptocurrency, Pew found. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
26 minutes ago
- Yahoo
German minister notes 'harsh tone' in US ahead of Merz-Trump meeting
German Foreign Minister Johann Wadephul has called for the preservation of the well-established US-German relations ahead of Chancellor Friedrich Merz's meeting with US President Donald Trump. "Yes, the tone hasn't been as harsh as this for a long time," Wadephul said in the evening at a meeting of former Arthur F Burns Fellowship scholars in Berlin. He diagnosed "profound changes in the US itself with an unknown outcome" and a new style of interaction following the Trump administration's inauguration, "which is unsettling and also disconcerting." However, the conservative politician stressed that one must "not panic." "Instead, we must endure this storm phase by first focusing on our own interests." This also means that Germany must strengthen its defence capabilities, safeguard its trade interests, and "articulate [its] understanding of freedom of expression and academic freedom." Wadephul, who visited the US capital Washington last week, assessed the talks with his US counterpart Marco Rubio as a positive signal: "They have made me confident that we can reach agreements in mutual interest even on issues where we have differences of opinion." Difficult talks for Merz Merz is travelling to the United States on Wednesday and is due to speak with Trump at the White House on Thursday. During the election campaign, the chancellor sharply criticized the US government's interference in German domestic politics. Currently, Trump's threat of permanently high tariffs on EU goods is also straining the relationship. With regard to the Ukraine war, Merz, along with other European leaders, is striving for a common stance with the US towards Russia. There is anticipation as to whether Merz will have to contend with a similarly unfriendly reception at the White House as, for example, Ukrainian President Volodymyr Zelensky. Wadephul stresses US support Wadephul emphasized that the US had repeatedly supported Germany after liberation from Nazi rule during reconstruction and also during reunification. "We should and will never forget that." The Arthur F Burns Fellowship is a trans-Atlantic exchange programme for journalists, named after a former US Federal Reserve chairman and ambassador to Germany.
